Altamira Therapeutics Announces Publication of Positive
Hamilton, Bermuda, April 24, 2024 (GLOBE NEWSWIRE) -- Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis...
Source: globenewswire.com
Nasdaq Cyto News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq Cyto. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Cyto Today - Breaking & Trending Today
Short Interest in Altamira Therapeutics Ltd. (NASDAQ:CYTO) Expands By 620.4%
Altamira Therapeutics Ltd. (NASDAQ:CYTO – Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 444,500 shares, an increase of 620.4% from the March 15th total of 61,700 shares. Based on an average daily volume of 1,140,000 shares, […]
Source: dailypolitical.com
Altamira Therapeutics' Peptide-Based Delivery Platform
HAMILTON, BERMUDA, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Independent peer-reviewed study shows enhanced cell transduction with adeno-associated virus...
Source: globenewswire.com
Altamira Therapeutics (NASDAQ:CYTO) Trading Down 2.2%
Altamira Therapeutics Ltd. (NASDAQ:CYTO – Get Free Report)’s stock price fell 2.2% on Thursday . The company traded as low as $1.80 and last traded at $1.81. 46,922 shares changed hands during trading, a decline of 76% from the average session volume of 192,669 shares. The stock had previously closed at $1.85. Altamira Therapeutics Stock […]
Source: tickerreport.com
Altamira Therapeutics Files Second Provisional Patent
HAMILTON, BERMUDA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Altamira’s polyKRASmut siRNA shown to knock down at least 65-91% of KRAS mutations in...
Source: globenewswire.com